Metalsource Mining Inc. has contracted Galt Consulting Group, operating as NaturalResourceStocks.net, for six months starting October 1, 2026, to increase investor awareness. The $28,000 agreement includes company interviews, website banner ads, and access to an investor email database. This move aims to enhance Metalsource's visibility without offering shares or options as compensation. Metalsource focuses on mineral exploration and aims to advance its mineral assets through systematic exploration.
Metalsource Mining's recent contract with NaturalResourceStocks.net is noted here with Pluang's Basic Materials sector data as of Sep 30, 2026 04:12 WIB. For readers following Basic Materials, here is Pluang's market snapshot: out of 38 priced US stocks, 10 rose and 28 fell. Notable movers include JCI at USD 150.33 with a 1-day change of +3.42% and a typical hold time of 65 days on Pluang, LYB at USD 58.15 down 3.39% with 100% buy order activity, and CF at USD 114.75 down 3.11% with 100% buy order activity. The most notable figure is JCI's 3.42% gain.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
